Page 159 - Read Online

Lu et al. Microbleeds and inflammatory marker levels

4. Yamashiro K, Tanaka R, Okuma Y, Shimura H, Ueno Y, Miyamoto N, 17. Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der
Urabe T, Hattori N. Cerebral microbleeds are associated with worse Lugt A, Witteman JC, Breteler MM, Mattace-Raso FU, Ikram MA.
cognitive function in the nondemented elderly with small vessel Arterial stiffness and cerebral small vessel disease: the Rotterdam
disease. Cerebrovasc Dis Extra 2014;4:212-20. Scan Study. Stroke 2012;43:2637-42.
5. Yamashiro K, Mori A, Shimada Y, Furuya T, Noda K, Urabe T, 18. Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van
Hattori N, Okuma Y. Gradient echo T2*-weighted magnetic resonance der Lugt A, Breteler MM. Prevalence and risk factors of cerebral
imaging revealing cerebral microbleeds in a patient with microscopic microbleeds: an update of the Rotterdam Scan Study. Stroke
polyangiitis complicated by cerebrovascular disease. J Stroke 2010;41:S103-6.
Cerebrovasc Dis 2012;21:904.e7-9. 19. Chung PW, Park KY, Kim JM, Shin DW, Ha SY. Carotid artery
6. Gregoire SM, Jäger HR, Yousry TA, Kallis C, Brown MM, Werring calcification is associated with deep cerebral microbleeds. Eur Neurol
DJ. Brain microbleeds as a potential risk factor for antiplatelet-related 2014;72:60-3.
intracerebral haemorrhage: hospital-based, case-control study. J 20. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ,
Neurol Neurosurg Psychiatry 2010;81:679-84. Krestin GP, Breteler MM, Vernooij MW. Cerebral microbleeds are
7. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio associated with worse cognitive function: the Rotterdam Scan Study.
E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. Neurology 2012;78:326-33.
C-reactive protein concentration and risk of coronary heart disease, 21. Gustavsson AM, Stomrud E, Abul-Kasim K, Minthon L, Nilsson
stroke, and mortality: an individual participant meta-analysis. Lancet PM, Hansson O, Nägga K. Cerebral microbleeds and white matter
2010;375:132-40. hyperintensities in cognitively healthy elderly: a cross-sectional
8. Patterson CC, Smith AE, Yarnell JW, Rumley A, Ben-Shlomo Y, cohort study evaluating the effect of arterial stiffness. Cerebrovasc
Lowe GD. The associations of interleukin-6 (IL-6) and downstream Dis Extra 2015;5:41-51.
inflammatory markers with risk of cardiovascular disease: the 22. Miwa K, Tanaka M, Okazaki S, Furukado S, Sakaguchi M, Kitagawa
Caerphilly Study. Atherosclerosis 2010;209:551-7. K. Relations of blood inflammatory marker levels with cerebral
9. Ramos-Fernandez M, Bellolio MF, Stead LG. Matrix microbleeds. Stroke 2011;42:3202-6.
metalloproteinase-9 as a marker for acute ischemic stroke: a systematic 23. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller
review. J Stroke Cerebrovasc Dis 2011;20:47-54. C, Vinters HV, Haacke EM, Holshouser B, Kido D, Kirsch WM.
10. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Correlation of hypointensites insusceptibility weighted images to
Jäger HR, Werring DJ. The Microbleed Anatomical Rating Scale
(MARS): reliability of a tool to map brain microbleeds. Neurology tissue hitology in dementia patients with cerebral amyloid angiopathy:
2009;73:1759-66. a postmortem MRI study. Acta Neuropathol 2010;119:291-302.
11. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen 24. Koh SH, Park CY, Kim MK, Lee KY, Kim J, Chang DI, Kim HT, Kim
WJ, Hofman A, Krestin GP, Breteler MM. Prevalence and risk factors SH. Microbleeds and free active MMP-9 are independent risk factors
of cerebral microbleeds: the Rotterdam Scan Study. Neurology for neurological deterioration in acute lacunar stroke. Eur J Neurol
2008;70:1208-11. 2011;8:158-64.
12. Goos JD, van der Flier WM, Knol DL, Pouwels P, Barkhof F, 25. Pantoni L. Cerebral small vessel disease: from pathogenesis and
Wattjes MP. Clinical relevance of improved microbleed detection clinical characteristics to therapeutic challenges. Lancet Neurol
by susceptibility-weighted magnetic resonance imaging. Stroke 2010;9:689-701.
2011;42:1894-900. 26. Piao MS, Lee JK, Park CS, Ryu HS, Kim SH, Kim HS. Early
13. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. activation of matrix metalloproteinase-9 is associated with blood-
Relations of serum high-sensitivity C-reactive protein and interleukin-6 brain barrier disruption after photothrombotic cerebral ischemia in
levels with silent brain infarction. Stroke 2005;36:768-72. rats. Acta Neurochir (Wien) 2009;151:1649-53.
14. Li J, Zhao Y, Mao J. Association between the extent of white matter 27. Jin R, Yang G, Li G. Molecular insights and therapeutic targets for
damage and early cognitive impairment following acute ischemic blood-brain barrier disruption in ischemic stroke: critical role of
stroke. Exp Ther Med 2017;13:909-12. matrix metalloproteinases and tissue-type plasminogen activator.
15. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain Neurobiol Dis 2010;38:376-85.
microbleeds: systematic review, subgroup analyses and standards for 28. Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, Vinters
study design and reporting. Brain 2007;130:1998-2003. HV, Haacke EM, Holshouser B, Kido D, Kirsch WM. Correlation of
16. Shams S, Martola J, Granberg T, Li X, Shams M, Fereshtehnejad hypointensities in susceptibility-weighted images to tissue histology
SM, Cavallin L, Aspelin P, Kristoffersen-Wiberg M, Wahlund LO. in dementia patients with cerebral amyloid angiopathy: a post-mortem
Cerebral microbleeds: different prevalence, topography, and risk MRI study. Acta Neuropathol 2010;119:291-302.
factors depending on dementia diagnosis -- the Karolinska Imaging 29. Kim BJ, Lee SH. Cerebral microbleeds: their associated factors,
Dementia Study. AJNR Am J Neuroradiol 2015;36:661-6. radiologic findings, and clinical implications. Stroke 2013;15:153-63.

Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ August 08, 2017 151